Resistant Hypertension in Chronic Kidney Disease: A Burden unto Itself.
作者信息
Shulman Rachel, Cohen Jordana B
机构信息
Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Clin J Am Soc Nephrol. 2022 Oct;17(10):1436-1438. doi: 10.2215/CJN.09720822. Epub 2022 Sep 9.
Abstract
摘要
相似文献
1
Resistant Hypertension in Chronic Kidney Disease: A Burden unto Itself.慢性肾脏病中的顽固性高血压：自身的负担
Clin J Am Soc Nephrol. 2022 Oct;17(10):1436-1438. doi: 10.2215/CJN.09720822. Epub 2022 Sep 9.
2
Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.限钠和利尿剂治疗在慢性肾脏病“顽固性”高血压中的作用
Semin Nephrol. 2014;34(5):514-9. doi: 10.1016/j.semnephrol.2014.08.005.
3
Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.难治性高血压与慢性肾脏病：一种危险的关联
Curr Hypertens Rep. 2016 Apr;18(5):36. doi: 10.1007/s11906-016-0641-x.
4
Recognition and Management of Resistant Hypertension.难治性高血压的识别与管理
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):524-535. doi: 10.2215/CJN.06180616. Epub 2016 Nov 28.
5
Managing hypertension in patients with chronic kidney disease.慢性肾脏病患者的高血压管理
JAAPA. 2014 Sep;27(9):37-46. doi: 10.1097/01.JAA.0000453239.92473.41.
6
[Diuretic agent].[利尿剂]
Nihon Rinsho. 2014 Aug;72(8):1472-6.
7
The double challenge of resistant hypertension and chronic kidney disease.耐药性高血压和慢性肾病的双重挑战。
Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3.
8
Hypertension Management in Transition: From CKD to ESRD.高血压管理的转变：从慢性肾脏病到终末期肾病
Adv Chronic Kidney Dis. 2016 Jul;23(4):255-61. doi: 10.1053/j.ackd.2016.02.002.
9
Resistant Hypertension in People With CKD: A Review.慢性肾脏病患者的耐药性高血压：综述。
Am J Kidney Dis. 2021 Jan;77(1):110-121. doi: 10.1053/j.ajkd.2020.04.017. Epub 2020 Jul 23.
10
Recent advances in the management of secondary hypertension: chronic kidney disease.继发性高血压的管理进展：慢性肾脏病
Hypertens Res. 2020 Sep;43(9):869-875. doi: 10.1038/s41440-020-0491-4. Epub 2020 Jun 17.
引用本文的文献
1
Long-term BPV is an Independent Risk Factor for Renal Prognosis in Hypertensive Patients - a Post-hoc Analysis of the SPRINT Study.长期血压变异性是高血压患者肾脏预后的独立危险因素——SPRINT研究的事后分析
Int J Med Sci. 2025 Apr 22;22(10):2298-2307. doi: 10.7150/ijms.111843. eCollection 2025.
2
Hyperaldosteronism Screening and Findings From a Large Diverse Population With Resistant Hypertension Within an Integrated Health System.醛固酮增多症筛查及综合健康体系中大量难治性高血压患者的研究结果。
Perm J. 2024 Mar 15;28(1):3-13. doi: 10.7812/TPP/23.096. Epub 2023 Nov 27.
本文引用的文献
1
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems.在美国两大医疗保健系统中慢性肾脏病中明显治疗抵抗性高血压的流行情况。
Clin J Am Soc Nephrol. 2022 Oct;17(10):1457-1466. doi: 10.2215/CJN.04110422. Epub 2022 Sep 9.
2
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD.KDIGO 美国专家组关于 2021 年改善慢性肾脏病患者血压管理的临床实践指南的解读。
Am J Kidney Dis. 2022 Mar;79(3):311-327. doi: 10.1053/j.ajkd.2021.09.013. Epub 2022 Jan 18.
3
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.氯沙坦治疗晚期慢性肾脏病的高血压。
N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730. Epub 2021 Nov 5.
4
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study.在美国退伍军人中进行原发性醛固酮增多症和盐皮质激素受体拮抗剂检测：一项回顾性队列研究。
Ann Intern Med. 2021 Mar;174(3):289-297. doi: 10.7326/M20-4873. Epub 2020 Dec 29.
5
Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency Cohort.与慢性肾功能不全队列中难治性和治疗抵抗性高血压相关的不良健康结局。
Hypertension. 2021 Jan;77(1):72-81. doi: 10.1161/HYPERTENSIONAHA.120.15064. Epub 2020 Nov 9.
6
Hypertension in CKD: Core Curriculum 2019.慢性肾脏病中的高血压：2019 年核心课程。
Am J Kidney Dis. 2019 Jul;74(1):120-131. doi: 10.1053/j.ajkd.2018.12.044. Epub 2019 Mar 19.
7
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.耐药性高血压：检测、评估与管理：美国心脏协会科学声明。
Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084.
8
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Hypertension. 2018 Jun;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13.
9
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.慢性肾脏病中貌似治疗抵抗性高血压的患病率及预后意义：慢性肾功能不全队列研究报告
Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.
Zotero 插件